Tierney Myers, a fourth-generation rodeo athlete and Texas native, competes in breakaway roping for Oklahoma State University, where she majors in agricultural communications. Her father, Rope, and ...
After signing off with co-host Sal Licata last week, Brandon Tierney had his own emotional farewell to WFAN Friday afternoon. WFAN is set to undergo a massive lineup change in January when Craig ...
KJ Muldoon received a groundbreaking new treatment earlier this year. The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ahead ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. The Food and Drug Administration this week granted approval to a new gene ...
Research links variations in the gene GRIN2A to a higher risk of developing schizophrenia and other forms of mental illness. The GRIN2A gene regulates communication between neurons by producing the ...
In a breakthrough study, scientists have discovered that a variant in one gene, GRIN2A, can directly cause mental illness – something previously believed to be the result of several mutations working ...
KISS frontman Gene Simmons got behind the White House crackdown on illegal immigration this week — as the star descended on DC for a pair of high-profile events that will take him from the Kennedy ...
Scientists have identified a protein that may be key to proper sperm formation. Without it, male mice produced no viable sperm, they found. A team at the RIKEN Center for Biosystems Dynamics Research ...
Revolutions in gene therapy are rapidly changing the landscape of modern medicine. Revolutions in gene therapy are rapidly changing the landscape of modern medicine, forcing society and science alike ...
Regeneron is adding its name to Tessera Therapeutics’ unique in vivo gene-writing program, inking a deal that lets it in on a prospect for alpha-1 antitrypsin deficiency (AATD) through a $150 million ...
Nov 24 (Reuters) - (This Nov 24 story has been corrected to fix the pricing for Zolgensma to $2.5 million from $2.1 million in paragraph 4) The U.S. Food and Drug Administration has approved Novartis' ...
HANOI/SINGAPORE, Nov 19 (Reuters) - Vietnam-founded biotechnology firm Gene Solutions plans to raise $100 million through a pre-IPO round and a potential listing as soon as 2026, capitalising on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback